Overview

PureTech Health is building the biopharma company of the future with an advanced, clinical stage pipeline of new medicines targeting serious diseases caused by dysfunctions in the brain, gut & immune systems.

For Investor Relations inquiries, please contact PureTech Health’s Investor Relations team at: ir@puretechhealth.com.

For more information, please use the links to the right.

Share Price

PureTech Health - Half-Year Report 2017

 

Advisors

SOLICITORS
DLA Piper UK LLP
3 Noble Street
London EC2V 7EE
United Kingdom
TEL: +44 870 011 1111

INDEPENDENT AUDITOR
KPMG LLP
15 Canada Square
London  E14 5GL
United Kingdom
TEL: +44 207 311 1000

MEDIA / PR
FTI Consulting, Inc.
200 Aldersgate
Aldersgate Street
London EC1A 4HD
United Kingdom
TEL: +44 203 727 1000

Registrar

Our share register is managed and administered by Computershare Investor Services PLC.
Computershare Investor Services PLC should be able to help you with most questions you may have about your PureTech Health PLC shares. 

Computershare Investor Services PLC
The Pavilions, Bridgwater Road
Bristol BS99 6ZZ
United Kingdom

Telephone UK: 0800 408 0094
Telephone Overseas: +44 870 889 3159
Email: web.queries@computershare.co.uk

Analyst Coverage

PETER WELFORD
Jefferies International Limited
68 Upper Thames Street
London EC4V 3BJ
United Kingdom
TEL: +44 (0)20 7029 8000

STEFAN HAMILL
Numis Securities Limited
The London Stock Exchange
Building, 10 Paternoster Square
London EC4M 7LT 
United Kingdom
TEL: +44 (0)20 7260 1000

AMY WALKER
Peel Hunt LLP
Moor House
120 London Wall
London EC2Y 5ET
United Kingdom
TEL: +44 (0)20 7418 8900

ROGER FRANKLIN
Liberum
Ropemaker Place
25 Ropemaker Street
London EC2Y 9LY
United Kingdom
TEL: +44 (0)20 3100 2096

SHEENA BERRY
N+1 Singer
One Bartholomew Lane
London EC2N 2AX
United Kingdom
TEL: +44 (0)20 7496 3000